Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Minopoulou I, Wilhelm A, Albach F, Kleyer A, Wiebe E, Schallenberg S, Fleischmann A, Frick M, Damm F, Gogolok J, Serve S, Locher BN, Borie D, Casteleyn V, Biesen R, Dörner T, Alexander T, Zernicke J, Movassaghi K, Hütter-Krönke ML, Schrezenmeier E, Schreiber A, Schneider U, Bullinger L, Krönke G, Penack O, Simon D.
Minopoulou I, et al. Among authors: simon d.
Ann Rheum Dis. 2025 Jan 31:S0003-4967(25)00053-6. doi: 10.1016/j.ard.2025.01.008. Online ahead of print.
Ann Rheum Dis. 2025.
PMID: 39893102
No abstract available.